25 November 2021

Biologics Conditions

What else is your hypertensive patient taking?

25 November 2021

The Back Page

We know you’re lying

25 November 2021

Who’s most at risk of dying from ILD complications?

25 November 2021

Conditions

Poppy seed tea leaves man with opioid addiction

25 November 2021

Biologics Comment COVID-19

Black Friday decision making, Covid and rituximab: is anyone buying?

25 November 2021

Research Technology

The personal health data revolution will be televised

25 November 2021

Corticosteroids COVID-19

Immunogenicity and benefits of third shot

25 November 2021 SPONSORED

Spondyloarthritis

Help protect rheumatoid arthritis patients against herpes zoster

18 November 2021

Tofacitinib safety study – more data released

18 November 2021

Biologics COVID-19

Cardiac toxicity risks with HCQ and CQ

18 November 2021

Comment Conditions

Myositis associated with gemcitabine

18 November 2021 SPONSORED

PROs Spondyloarthritis

Are you optimising MTX treatment for RA patients?

18 November 2021

The Back Page

Fatal retraction

18 November 2021

Comment Evidence Based RedHerring TGA

Private health insurance must kick its alt-med habit

18 November 2021

Evidence Based O&G RedHerring

Debunk health myths with these three steps

18 November 2021

Biologics Conditions

Slow-release opioid therapy helps GPs treat illicit drug use